Search results
Added:
3 years ago
Cardiovascular (CV) disease is the leading cause of death worldwide.1 Age, sex and genetic factors have a major impact on CV risk. The importance of behavioural factors, such as tobacco and alcohol use, physical inactivity, unhealthy diet and obesity, is often neglected, although the implementation of lifestyle changes may be a cost-effective strategy for the prevention of CV diseases, also from…
View more
Added:
2 years ago
CVD in Female Athletes
Added:
2 years ago
Article
Added:
3 years ago
Smoking is a strong risk factor for the development of arteriosclerotic cardiovascular disease (CVD). Quitting smoking is a cornerstone of improved cardiovascular health, reducing the risk of developing CVD and the risk of overall mortality.1 It is astonishing that 7–28% of patients with coronary heart disease still smoke, but around half of smokers are planning to quit.2,3 Because the habit is…
View more
Added:
3 years ago
Primordial Prevention – What Does It Mean?
In 1978, Strasser suggested that prevention of cardiovascular disease (CVD) should go beyond the concept of primary prevention. He coined the term ‘primordial prevention’ to denote activities that prevented the penetration of risk factors into the population1 by intervening to stop the appearance of the risk factors. The 3rd International Heart Health…
View more
Added:
3 years ago
There is a great concern among both health professionals and the public about the best way of managing the current explosion in adult and adolescent obesity. In the US, the prevalence of obese teenagers between 1980 and 2007 increased from 5 to 18 %1 and the UK has seen a similar trend, especially in boys (see Figure 1). Since a substantial proportion of obese teenagers become obese adults,2,3 it…
View more
Added:
1 year ago
In the second part of ECR Podcast's series on sex differences in hypertension, Dr Isabella Sudano (University Hospital and University of Zurich, Zurich, CH) and Dr Eva Gerdts (Haukeland University Hospital, Bergen, NO) are joined by Dr Angela Maas (Radboud University Medical Center, Nijmegen, NL) to talk about the cardiovascular complications that may arise in women as a result of hypertension.
…
View more
Added:
3 years ago
The primary goal in the treatment of hypertensive patients is to achieve the maximum possible reduction in the long-term total risk of cardiovascular (CV) and renal morbidity and mortality. In addition to the lowering of blood pressure (BP) per se, successful realisation of the primary goal of treatment also requires appropriate consideration of co-morbidities.1–3 Although there is some…
View more
Added:
7 months ago
ESC 2023 — Dr Ramón Luengo-Fernández (University of Oxford, UK) joins us on-site to discuss the findings from a registry which aimed to analyse the economic burden of cardiovascular disease within the EU.
This was the first study to utilise Europe-wide patient registries and included the costs of long-term social care. Results from the registry found that cardiovascular disease cost the EU €282…
View more
Added:
2 years ago
« First